Department of Medical Genetics, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.
ELKH-SZTE Functional Clinical Genetics Research Group, Eötvös Loránd Research Network, 6720 Szeged, Hungary.
Int J Mol Sci. 2023 Apr 17;24(8):7401. doi: 10.3390/ijms24087401.
Hearing loss is the most prevalent sensory disorder worldwide. The majority of congenital nonsyndromic hearing loss (NSHL) cases are caused by hereditary factors. Previously, the majority of NSHL studies focused on the gene; however, with the availability of next-generation sequencing (NGS) methods, the number of novel variants associated with NSHL has increased. The purpose of this study was to design effective genetic screening for a Hungarian population based on a pilot study with 139 NSHL patients. A stepwise, comprehensive genetic approach was developed, including bidirectional capillary sequencing, multiplex ligation-dependent probe amplification (MLPA), and an NGS panel of 108 hearing loss genes. With our results, a genetic diagnosis was possible for 92 patients. Sanger sequencing and MLPA identified the genetic background of 50% of these diagnosed cases, and the NGS panel identified another 16%. The vast majority (92%) of the diagnosed cases showed autosomal recessive inheritance and 76% were attributed to . The implementation of this stepwise analysis markedly increased our diagnostic yield and proved to be cost-effective as well.
听力损失是全球最常见的感觉障碍。大多数先天性非综合征性听力损失 (NSHL) 是由遗传因素引起的。以前,大多数 NSHL 研究都集中在基因上;然而,随着下一代测序 (NGS) 方法的出现,与 NSHL 相关的新变体数量有所增加。本研究旨在基于对 139 名 NSHL 患者的初步研究,为匈牙利人群设计有效的遗传筛查。采用逐步、全面的遗传方法,包括双向毛细管测序、多重连接依赖性探针扩增 (MLPA) 和 108 个听力损失基因的 NGS 面板。根据我们的结果,对 92 名患者进行了基因诊断。Sanger 测序和 MLPA 确定了 50%已诊断病例的遗传背景,而 NGS 面板又确定了另外 16%的病例。绝大多数(92%)已诊断病例表现为常染色体隐性遗传,76%归因于。分步分析的实施显著提高了我们的诊断率,并且证明是具有成本效益的。